HomeNewsOpinionHas the WTO ministerial conference met India’s long-term concerns?

Has the WTO ministerial conference met India’s long-term concerns?

India should be disappointed as a permanent solution on public stockholding of food grains was not discussed at the 12th Ministerial Conference 

June 21, 2022 / 16:55 IST
Story continues below Advertisement
India should be disappointed as a permanent solution on public stockholding of food grains was not discussed at the MC12
India should be disappointed as a permanent solution on public stockholding of food grains was not discussed at the MC12

The World Trade Organization (WTO) convened its 12th Ministerial Conference (MC12) in Geneva when questions regarding the legitimacy of the organisation were the loudest since its establishment nearly four decades back, mainly due to its inability to take decisions. Therefore, when the MC12 ministerial decisions were finally adopted unanimously after extended deliberations, the sense of achievement is understandable. Now is the time to dispassionately analyse the outcomes, and to what extent the outcomes meet the expectations of India.

In the wake of COVID-19, India had taken a significant initiative to re-orient the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) so that developing countries can get affordable access to vaccines, therapeutics, and other products necessary for overcoming the scourge of the pandemic. After a considerable hiatus, India took the responsibility of addressing the concerns of developing countries alongside its long-time partner, South Africa.

Story continues below Advertisement

The two countries brought a proposal in October 2020 seeking temporary waiver from the implementation, application, and enforcement of four forms of intellectual property rights (IPRs), namely: patents, copyright, industrial designs, and protection of undisclosed information or trade secrets. This proposal was co-sponsored by 63 other WTO members, and was supported by almost two-thirds of the membership. The proponents argued that granting of the waiver during the pendency of the pandemic would facilitate access to the technologies for producing the products necessary for COVID-19 treatment, enabling large-scale production.

However, the advanced countries that were backing their pharmaceutical companies, opposed the ‘waiver proposal’, with the European Union (EU) tabling a counter, proposing that compulsory licenses (CLs) on patented vaccines should granted for increasing production. Earlier this year, the EU proposal was granted legitimacy through informal consultations involving the United States, South Africa, and India, which was facilitated by the Director General of the WTO Ngozi Okonjo-Iweala. At the end of this process, the ‘waiver proposal’ was effectively side-lined, and the EU proposal on the granting of CLs was accepted, based on which the ministerial decision was adopted.